We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

258 hedge funds and large institutions have $2.75B invested in Myriad Genetics in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 76 increasing their positions, 95 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $8.79M | Put options by funds: $6.51M

23% more capital invested

Capital invested by funds: $2.22B → $2.75B (+$522M)

1% less funds holding

Funds holding: 260 → 258 (-2)

3% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 35

2.68% less ownership

Funds ownership: 107.76% → 105.08% (-2.7%)

20% less repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 95

Holders
258
Holders Change
-2
Holders Change %
-0.77%
% of All Funds
5.91%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
34
Increased
76
Reduced
95
Closed
35
Calls
$8.79M
Puts
$6.51M
Net Calls
+$2.27M
Net Calls Change
-$1.65M

Top Buyers

1
BlackRock
BlackRock
New York
+$23.3M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$17.4M
3
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Illinois
+$13.5M
4
FCM
Frontier Capital Management
Massachusetts
+$12.3M
5
Millennium Management
Millennium Management
New York
+$9.86M

Top Sellers

1
State Street
State Street
Massachusetts
-$17.2M
2
Goldman Sachs
Goldman Sachs
New York
-$17.1M
3
SI
Sensato Investors
California
-$16.4M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$15.6M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$15.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Tudor Investment Corp
101
Tudor Investment Corp
Connecticut
$1.54M +$825K +24,439 +145%
CIP
102
Convergence Investment Partners
Florida
$1.48M -$2.85M -84,264 -68%
CAM
103
ClariVest Asset Management
California
$1.46M +$1.32M +39,092 +205,747%
FIM
104
Freedom Investment Management
Connecticut
$1.4M +$348K +10,313 +38%
CM
105
CS McKee
Pennsylvania
$1.39M -$118K -3,500 -9%
SFM
106
Systematic Financial Management
New Jersey
$1.39M -$280K -8,280 -18%
PA
107
Profund Advisors
Maryland
$1.38M +$3.61K +107 +0.3%
USAA
108
United Services Automobile Association
Texas
$1.38M +$92.7K +2,746 +8%
Renaissance Technologies
109
Renaissance Technologies
New York
$1.38M -$6.03M -178,474 -83%
Barclays
110
Barclays
United Kingdom
$1.35M -$1.53M -45,427 -56%
OAM
111
Oxford Asset Management
United Kingdom
$1.35M +$1.23M +36,319 New
SO
112
STRS Ohio
Ohio
$1.34M -$135K -4,000 -10%
TAM
113
Tocqueville Asset Management
New York
$1.31M -$270 -8 -0%
LSERS
114
Louisiana State Employees Retirement System
Louisiana
$1.17M +$10.1K +300 +1%
SSCM
115
Summit Street Capital Management
New York
$1.13M – – –
MIM
116
MetLife Investment Management
New Jersey
$1.11M – – –
1CM
117
1492 Capital Management
Wisconsin
$1.09M +$288K +8,532 +41%
Jennison Associates
118
Jennison Associates
New York
$1.07M +$20.7K +613 +2%
VRS
119
Virginia Retirement Systems
Virginia
$1.07M +$966K +28,600 New
CA
120
Continental Advisors
Utah
$972K – – –
LPIC
121
LeJeune Puetz Investment Counsel
Michigan
$916K -$152K -4,500 -16%
T. Rowe Price Associates
122
T. Rowe Price Associates
Maryland
$907K +$2.57K +76 +0.3%
FRM
123
Fox Run Management
Connecticut
$906K +$818K +24,231 New
MSL
124
Mackay Shields LLC
New York
$901K -$16.9K -500 -2%
GAM
125
Gotham Asset Management
New York
$888K -$311K -9,220 -28%
3 4
5
6 7

MYGN Hedge Fund Activity: Q2 2018 in Review

258 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q2 2018, worth a combined $2.75B — up 23% from $2.22B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of MYGN and 34 opened new positions — a net loss of 1 holder — while 95 trimmed existing stakes and 76 added.

The largest buyer was BlackRock, adding an estimated $23.3M. The largest seller was State Street, cutting an estimated $17.2M.

  • 258 institutional investors held Myriad Genetics (MYGN) as of Q2 2018, down from 260 in Q1 2018.
  • Funds reported $2.75B of Myriad Genetics stock for Q2 2018, up 23% quarter-over-quarter.
  • 34 funds opened new Myriad Genetics positions in Q2 2018 and 35 closed out, a net change of -1 holder.
  • The largest Myriad Genetics buyer in Q2 2018 was BlackRock, an estimated $23.3M added.
  • The largest Myriad Genetics seller in Q2 2018 was State Street, an estimated $17.2M sold.

Based on aggregated 13F filings for Q2 2018.